Literature DB >> 20467932

[Obesity: ectopic fat distribution and the heart].

Dirk Müller-Wieland1, Birgit Knebel, Jutta Haas, Martin Merkel, Jörg Kotzka.   

Abstract

The metabolic syndrome is usually associated with insulin resistance and visceral fat distribution, which appear to play a direct role in the development of clinical criteria of metabolic syndrome, like elevation of arterial blood pressure and dyslipidemia. In this review, the authors will first introduce the concept, that insulin resistance and increased visceral adipose tissue are also regularly associated with an abnormal or ectopic accumulation of lipids in nonadipocytes, like steatosis hepatis. Then, they will provide some evidence that epicardial fat can be associated with insulin resistance in a similar fashion as visceral intraabdominal fat. Furthermore, epicardial fat might directly affect the vessels and function of the heart. Accordingly, ectopic accumulation of fat within cardiac muscle cells can impair their function and possibly be related to heart failure. These new relations between obesity, fat distribution and cardiac function might help to identify and treat individuals at risk earlier and more appropriately.

Entities:  

Mesh:

Year:  2010        PMID: 20467932     DOI: 10.1007/s00059-010-3344-0

Source DB:  PubMed          Journal:  Herz        ISSN: 0340-9937            Impact factor:   1.443


  33 in total

Review 1.  Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition.

Authors:  Scott M Grundy; H Bryan Brewer; James I Cleeman; Sidney C Smith; Claude Lenfant
Journal:  Circulation       Date:  2004-01-27       Impact factor: 29.690

2.  Epicardial and pericardial fat: close, but very different.

Authors:  Gianluca Iacobellis
Journal:  Obesity (Silver Spring)       Date:  2009-04       Impact factor: 5.002

Review 3.  Lipotoxic diseases.

Authors:  Roger H Unger
Journal:  Annu Rev Med       Date:  2002       Impact factor: 13.739

4.  Myocardial triglyceride content and epicardial fat mass in human obesity: relationship to left ventricular function and serum free fatty acid levels.

Authors:  Mikko Kankaanpää; Hanna-Riikka Lehto; Jussi P Pärkkä; Markku Komu; Antti Viljanen; Ele Ferrannini; Juhani Knuuti; Pirjo Nuutila; Riitta Parkkola; Patricia Iozzo
Journal:  J Clin Endocrinol Metab       Date:  2006-08-22       Impact factor: 5.958

5.  Pericardial fat, visceral abdominal fat, cardiovascular disease risk factors, and vascular calcification in a community-based sample: the Framingham Heart Study.

Authors:  Guido A Rosito; Joseph M Massaro; Udo Hoffmann; Frederick L Ruberg; Amir A Mahabadi; Ramachandran S Vasan; Christopher J O'Donnell; Caroline S Fox
Journal:  Circulation       Date:  2008-01-22       Impact factor: 29.690

6.  Elevation of free fatty acids induces inflammation and impairs vascular reactivity in healthy subjects.

Authors:  Devjit Tripathy; Priya Mohanty; Sandeep Dhindsa; Tufail Syed; Husam Ghanim; Ahmad Aljada; Paresh Dandona
Journal:  Diabetes       Date:  2003-12       Impact factor: 9.461

7.  Contribution of glucose tolerance and gender to cardiac adiposity.

Authors:  Patricia Iozzo; Riikka Lautamaki; Ronald Borra; Hanna-Riikka Lehto; Marco Bucci; Antti Viljanen; Jussi Parkka; Virva Lepomaki; Romina Maggio; Riitta Parkkola; Juhani Knuuti; Pirjo Nuutila
Journal:  J Clin Endocrinol Metab       Date:  2009-10-09       Impact factor: 5.958

8.  Aerobic exercise training reduces epicardial fat in obese men.

Authors:  Maeng-Kyu Kim; Tsugio Tomita; Mi-Ji Kim; Hiroyuki Sasai; Seiji Maeda; Kiyoji Tanaka
Journal:  J Appl Physiol (1985)       Date:  2008-10-16

Review 9.  Disordered lipid metabolism and the pathogenesis of insulin resistance.

Authors:  David B Savage; Kitt Falk Petersen; Gerald I Shulman
Journal:  Physiol Rev       Date:  2007-04       Impact factor: 37.312

Review 10.  Building bone to reverse osteoporosis and repair fractures.

Authors:  Sundeep Khosla; Jennifer J Westendorf; Merry Jo Oursler
Journal:  J Clin Invest       Date:  2008-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.